Radiopharm Theranostics (ASX:RAD) Net Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Radiopharm Theranostics's Net Income for the six months ended in Dec. 2023 was A$-24.76 Mil. Radiopharm Theranostics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Radiopharm Theranostics's net margin for the quarter that ended in Dec. 2023 was 0.00%.

The historical rank and industry rank for Radiopharm Theranostics's Net Margin % or its related term are showing as below:

ASX:RAD' s Net Margin % Range Over the Past 10 Years
Min: -337100 Med: -174476.54 Max: -11853.08
Current: -11853.08

ASX:RAD's Net Margin % is ranked worse than
91.63% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs ASX:RAD: -11853.08

Radiopharm Theranostics Net Margin % Historical Data

The historical data trend for Radiopharm Theranostics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Net Margin % Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Net Margin %

-337,100.00

-11,853.08

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	-	-	-4,298.63	-	-

Competitive Comparison of Radiopharm Theranostics's Net Margin %

For the Biotechnology subindustry, Radiopharm Theranostics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Net Margin % falls into.

Radiopharm Theranostics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Radiopharm Theranostics's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-34.611	/	0.292
	=	-11,853.08 %

Radiopharm Theranostics's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-24.758	/	0
	=	%

Radiopharm Theranostics (ASX:RAD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Radiopharm Theranostics Net Margin % Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines